Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles
Open Access
- 30 June 2005
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 35 (7) , 2122-2130
- https://doi.org/10.1002/eji.200526059
Abstract
Virus-like particles containing the rotavirus (RV) internal proteins VP2 and VP6 (2/6-VLP) have been shown to induce serum and fecal antibodies as well as protection in mice after intranasal administration with a mutant of E. coli toxin, LT-R192G. To better understand the origin of fecal IgA induced by this protocol, we studied the RV-specific B cell response in systemic and mucosal lymphoid tissues using a flow cytometry assay that allows quantification and phenotypic characterization of RV-specific B lymphocytes. We also assessed the RV-specific antibody-secreting cells in the spleen and intestinal lamina propria (ILP). A remarkably high frequency of RV-specific B cells was found in the respiratory lymphoid tissues and spleen, of which only a minority expressed the α4β7 integrin (intestinal homing receptor). In contrast, but in accordance with α4β7 expression at the induction site, a very low response was observed in intestinal lymphoid tissues (mesenteric lymph nodes and ILP), which did not increase after a second immunization. Thus, intranasal immunization with a nonreplicating antigen does not induce an important number of RV-specific B cells with an intestinal homing profile.Keywords
This publication has 33 references indexed in Scilit:
- Plasma-cell homingNature Reviews Immunology, 2003
- Global Illness and Deaths Caused by Rotavirus Disease in ChildrenEmerging Infectious Diseases, 2003
- Heterologous Protection Induced by the Inner Capsid Proteins of Rotavirus Requires Transcytosis of Mucosal ImmunoglobulinsJournal of Virology, 2002
- Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6–specific IgA mAbJournal of Clinical Investigation, 2002
- Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin andEscherichia coliHeat-Labile Toxin, Induce a Th1/Th2-Like Immune ResponseJournal of Virology, 2001
- Protective Efficacy of Rotavirus 2/6-Virus-Like Particles Combined with CT-E29H, a Detoxified Cholera Toxin AdjuvantViral Immunology, 2001
- Protective Intestinal Anti-Rotavirus B Cell Immunity Is Dependent on α4β7 Integrin Expression But Does Not Require IgA Antibody ProductionThe Journal of Immunology, 2001
- Rotavirus vaccinesCurrent Opinion in Infectious Diseases, 2000
- Comparison of Murine Nasal-associated Lymphoid Tissue and Peyer's PatchesAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.Journal of Clinical Investigation, 1997